Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|July 12, 2017
Testing PARP Inhibitors Using a Murine Xenograft ModelPeter Makhov, Sei Naito, Vladimir M Kolenko
Cancers|February 10, 2024
Targeting NPC1 in Renal Cell CarcinomaRushaniya Fazliyeva, Peter Makhov, Robert G Uzzo, et al.
Urologic Oncology|May 14, 2020
Histone-dependent PARP-1 inhibitors: A novel therapeutic modality for the treatment of prostate and renal cancersPeter Makhov, Robert G Uzzo, Alexei V Tulin, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 14, 2022
Examining the Effect of PARP-1 Inhibitors on Transcriptional Activity of Androgen Receptor in Prostate Cancer CellsPeter Makhov, Rushaniya Fazliyeva, Antonio Tufano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
Overexpression of the zinc uptake transporter hZIP1 inhibits nuclear factor-kappaB and reduces the malignant potential of prostate cancer cells in vitro and in vivoKonstantin Golovine, Peter Makhov, Robert G Uzzo, et al.
Molecular Cancer Therapeutics|July 4, 2018
Resistance to Systemic Therapies in Clear Cell Renal Cell Carcinoma: Mechanisms and Management StrategiesPeter Makhov, Shreyas Joshi, Pooja Ghatalia, et al.
The Prostate|February 11, 2011
Docetaxel-mediated apoptosis in myeloid progenitor TF-1 cells is mitigated by zinc: potential implication for prostate cancer therapyPeter Makhov, Alexander Kutikov, Konstantin Golovine, et al.
Gene|November 26, 2008
Transcriptional regulation of the major zinc uptake protein hZip1 in prostate cancer cellsPeter Makhov, Konstantin Golovine, Robert G Uzzo, et al.
Pageof 3